Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Price

Showing results (211-220 of 635) with videos related to

Pageof 64
Sort By:
Pharmacoeconomics|January 19, 2013
Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approachYumi Asukai, Michael Baldwin, Tiago Fonseca, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|July 16, 2008
The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient managementPaul Van Cauwenberge, Helen Van Hoecke, Peter Kardos, et al.
Journal of Diabetes Science and Technology|January 17, 2018
Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring SystemPeter Calhoun, Terri Kang Johnson, Jonathan Hughes, et al.
Nature|December 16, 2005
Efficacy of the post-perovskite phase as an explanation for lowermost-mantle seismic propertiesJames Wookey, Stephen Stackhouse, J-Michael Kendall, et al.
Respiratory Medicine|July 14, 2021
The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbiditiesVasilis Nikolaou, Sebastiano Massaro, Wolfgang Garn, et al.
Applied Health Economics and Health Policy|March 27, 2013
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource useDavid Price, Yumi Asukai, Jaithri Ananthapavan, et al.
BMC Pulmonary Medicine|January 7, 2010
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label studyDavid Price, Anne Robertson, Kevin Bullen, et al.
Pragmatic and Observational Research|August 23, 2012
The challenge of recruiting in primary care for a trial of telemonitoring in asthma: an observational studyShweta Malhotra, Stanley D Musgrave, Hilary Pinnock, et al.
Healthcare Quarterly (Toronto, Ont.)|May 28, 2014
Developing an institute of medicine-aligned framework for categorizing primary care indicators for quality assessmentCheryl Levitt, Xingchen Chen, Linda Hilts, et al.
NPJ Primary Care Respiratory Medicine|July 18, 2014
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?David Price, Leonard Fromer, Alan Kaplan, et al.
Pageof 64

Showing results (211-220 of 635) with videos related to

Sort By:
Pageof 64
Pharmacoeconomics|January 19, 2013
Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approachYumi Asukai, Michael Baldwin, Tiago Fonseca, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|July 16, 2008
The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient managementPaul Van Cauwenberge, Helen Van Hoecke, Peter Kardos, et al.
Journal of Diabetes Science and Technology|January 17, 2018
Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring SystemPeter Calhoun, Terri Kang Johnson, Jonathan Hughes, et al.
Nature|December 16, 2005
Efficacy of the post-perovskite phase as an explanation for lowermost-mantle seismic propertiesJames Wookey, Stephen Stackhouse, J-Michael Kendall, et al.
Respiratory Medicine|July 14, 2021
The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbiditiesVasilis Nikolaou, Sebastiano Massaro, Wolfgang Garn, et al.
Applied Health Economics and Health Policy|March 27, 2013
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource useDavid Price, Yumi Asukai, Jaithri Ananthapavan, et al.
BMC Pulmonary Medicine|January 7, 2010
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label studyDavid Price, Anne Robertson, Kevin Bullen, et al.
Pragmatic and Observational Research|August 23, 2012
The challenge of recruiting in primary care for a trial of telemonitoring in asthma: an observational studyShweta Malhotra, Stanley D Musgrave, Hilary Pinnock, et al.
Healthcare Quarterly (Toronto, Ont.)|May 28, 2014
Developing an institute of medicine-aligned framework for categorizing primary care indicators for quality assessmentCheryl Levitt, Xingchen Chen, Linda Hilts, et al.
NPJ Primary Care Respiratory Medicine|July 18, 2014
Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?David Price, Leonard Fromer, Alan Kaplan, et al.
Pageof 64